Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet

Obesity

Volumn 16, Issue 1, 2008, Pages 40-46

  Reimer, Raylene A ^a   Russell, James C ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INULIN; LIPID; MESSENGER RNA; PROGLUCAGON;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; COMPARATIVE STUDY; DIETARY FIBER; DISEASE MODEL; DRUG EFFECT; DUODENUM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; JEJUNUM; MALE; METABOLISM; OBESITY; PATHOLOGY; PHYSIOLOGY; PROTEIN INTAKE; RAT; RAT STRAIN; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FIBER; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; DUODENUM; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; INULIN; JEJUNUM; LIPIDS; MALE; OBESITY; PROGLUCAGON; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; WEIGHT GAIN;

RATTUS;

EID: 39449087086     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.16     Document Type: Article

References (59)

1. Delzenne NM. Oligosaccharides: state of the art. Proc Nutr Soc 2003;62: 177-182.
2. Roberfroid MB. Prebiotics: preferential substrates for specific germs? Am J Clin Nutr 2001 ;73:406S-409S.
3. Cani PD, Joly E, Horsmans Y, Delzenne NM. Oligofructose promotes satiety in healthy humans: a pilot study. Eur J Clin Nutr 2006;60:567-572.
4. Yamashita K, Itakura M, Kawai K. Effect of fructo-oligosaccharides on blood glucose and serum lipids In diabetic subjects. Nutr Res 1984;4:961-966.
5. Piche T, des Varannes SB, Sacher-Huvelin S et al. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 2003;124:894-902.
6. Delzenne NM, Williams CM. Prebiotics and lipid metabolism. Curr Opin Lipidol 2002;13:61-67.
7. Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3:153-165.
8. McBurney MI, Reimer RA, Tappenden KA. Short chain fatty acids, intestinal adaptation, and nutrient utilization. In: Kritchevsky D, Bonfield C (eds). Dietary Fiber in Health and Disease. Plenum Press: New York, 1997, pp 135-143.
9. Reimer RA, McBurney MI. Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology 1996;137:3948-3956.
10. Reimer RA, Thomson AB, Rajotte R et al. A physiological level of rhubarb fiber increases proglucagon gene expression and modulates intestinal glucose uptake in rats. J Nutr 1997;127:1923-1928.
11. Reimer RA, Thomson AB, Rajotte R et al. Proglucagon messenger ribonucleic acid and intestinal glucose uptake are modulated by fermentable fiber and food intake in diabetic rats. Nutr Res 2000;20:851-864.
12. Daubioul C, Rousseau N, Demeure R et al. Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr 2002;132:967-973.
13. Cani PD, Neyrinck AM, Maton N, Delzenne NM. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes Res 2005;13:1000-1007.
14. Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese Zucker rats. J Nutr 2000;130:1314-1319.
15. Cani PD, Daubioul CA, Reusens B et al. Involvement of endogenous glucagon-like peptide-1 (7-36) amide on glycemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 2005;185:457-465.
16. Delmee E, Cani PD, Gual G et al. Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci 2006;79:1007-1013.
17. Kok NN, Morgan LM, Williams CM et al. Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. J Nut 1998;128:1099-1103.
18. Cani PD, Knauf C, Iglesias MA et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide-1 receptor. Diabetes 2006;55:1484-1490.
19. Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 2004;92:521-526.
20. Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug Discov Today 2003;8:692-700.
21. Anderson GH, Moore SE. Dietary proteins In the regulation of food intake and body weight in humans. J Nutr 2004;134:974S-979S.
22. Halton TL, Hu FB. The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review. J Am Coll Nutr 2004;23:373-385.
23. Bowen J, Noakes M, Clifton PM. Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake. J Clin Endocrinol Metab 2006;91 : 2913-2919.
24. Lejeune MP, Westererp KR, Adam TC, Luscombe-Marsh ND, Westererp-Plantenga RS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr 2006;83:89-94.
25. Blom WA, Lluch A, Stafleu A et al. Effect of a high-protein breakfast on the postprandial ghrelin response. Am J Clin Nutr 2006;83:211-220.
26. Foster GD, Wyatt HR, Hill JO et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003;348:2082-2090.
27. Brehm BJ, Seeley RJ, Daniels SR, D'Alesslo DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 2003;88:1617-1623.
28. Samaha FF, Iqbal N, Seshadri P et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074-2081.
29. Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia. Ann Intern Med 2004;140:769-777.
30. Reimer RA, Darimont C, Gremlich S et al. A human cellular model for studying the regulation of glucagon-like peptide 1 secretion. Endocrinology 2001;142:4522-4528.
31. Reimer RA. Meat hydrolysate and essential amino acid-induced glucagon like peptide-1 secretion in the human enteroendocrine NCl-H716 cell line is regulated by extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinases. J Endocrinol 2006;190:1-13.
32. Koletsky S. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 1975;80:129-142.
33. Russell JC, Graham S, Hameed M. Abnormal insulin and glucose metabolism in the JCR:La-corpulent rat. Metabolism 1994;43:538-543.
34. Russell JC, Koeslag DG, Amy RM, Dolphin PJ. Plasma lipid secretion and clearance in hyperlipidemic JCR:La-corpulent rats. Arterioscierosis 1989;9:869-876.
35. Amy RM, Dolphin PJ, Pederson RA, Russell JC. Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N corpulent. Atherosclerosis 1988;69:199-209.
36. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991 ;14:173-194.
37. Drucker DJ. Development of glucagon-like peptide-1 -based pharmaceuticals as therapeutic agents for the treatments of diabetes. Curr Pharm Des 2001 ;7:1399-1412.
38. Massimino S, McBurney MI, Field CJ et al. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite intestinal glucose transport capacity in healthy dogs. J Nutr 1998;128:1786-1793.
39. Deng MY, Wang H, Ward GB, Beckham TR, McKenna TS. Comparison of six RNA extraction methods for the detection of classical swine fever virus by real-time and conventional reverse transcriptase-PCR. J Vet Diagn Invest 2005;17:574-578.
40. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 ;25: 402-408.
41. Russell JC, Ravel D, Pegorier JP et al. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JRC:LA-cp rat. J Pharmacol Exp Ther 2000;295:753-760.
42. Russell JC, Graham SE, Dolphin PJ. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099). Metabolism 1999;48:701-706.
43. Russell JC, Kelly SE, Schafer S. Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat. J Cardiovasc Pharmacol 2004;44:258-265.
44. Moughan PJ, Butts CA, Rowan AM, Deglaire A. Dietary peptides increase endogenous amino acid losses from the gut in adults. Am J Clin Nutr 2005;81:1359-1365.
45. Pannacciulli N, Bunt JC, Koska J, Bogardus C, Krakoff J. Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans. Am J Clin Nutr 2006;84:556-560.
46. Hoist JJ, Deacon CF. Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 2005;48:612-615.
47. Kok NN, Roberfroid M, Delzenne NM. Dietary OFS modifies the impact of fructose on hepatic triacylglerol metabolism. Metabolism 1996;45:1547-1550.
48. Delzenne NM, Kok NN. Biochemical basis of oligofructose-induced hypolipidemia in animal models. J Nutr 1999;129:1467S-1470S.
49. Deng X, Elam MB, Wilcox HG et al. Dietary olive oil and menhaden oil mitigate induction of lipogenesis in hyperinsulinemic corpulent JCR:LA-cp rats: microarray analysis of lipid-related gene expression. Endocrinology 2004;145:5847-5861.
50. Capell WH, Eckel RH. Treatment of hypertriglyceridemia. Curr Diab Rep 2006;6:230-240.
51. Rizzo M, Bernels K. Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? J Atheroscler Thromb 2005;12:237-239.
52. Staels B, van Tol A, Andreu T, Auwerx J. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscier Thromb 1992;12:286-294.
53. Malmendier CL, Delecroix C. Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia. Atherosclerosis 1985;55:161-169.
54. Sirtori CR, Franceshini G. Effects of fibrates on serum lipids and atherosclerosis. Pharmacol Ther 1988;37:167-191.
55. Beylot M. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 2005;93(Suppl 1):S163-S168.
56. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235-243.
57. Nyman M. Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br J Nutr 2002;87(Suppl 2):S163-S168.
58. Van Loo J, Franck A, Roberfroid M. Functional food properties of non-digestible oligosaccharides - reply. Br J Nutr 1999;82:329.
59. Mantha L, Russell JC, Brindley DN, Deshaies Y. Developmental changes in adipose and muscle lipoprotein lipase activity in the atherosclerosis-prone JCR:La-corpulent rat. Int J Obes Relet Metab disord 2002;26:308-317.